Baxter International Inc (BAX)
35.25
-0.18
(-0.51%)
USD |
NYSE |
May 16, 14:33
Baxter International Enterprise Value: 28.82B for May 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 28.82B |
| May 14, 2024 | 28.72B |
| May 13, 2024 | 28.82B |
| May 10, 2024 | 28.95B |
| May 09, 2024 | 29.08B |
| May 08, 2024 | 28.98B |
| May 07, 2024 | 29.17B |
| May 06, 2024 | 29.37B |
| May 03, 2024 | 29.56B |
| May 02, 2024 | 29.57B |
| May 01, 2024 | 31.32B |
| April 30, 2024 | 31.33B |
| April 29, 2024 | 31.47B |
| April 26, 2024 | 31.21B |
| April 25, 2024 | 31.26B |
| April 24, 2024 | 31.62B |
| April 23, 2024 | 31.66B |
| April 22, 2024 | 31.35B |
| April 19, 2024 | 30.87B |
| April 18, 2024 | 30.97B |
| April 17, 2024 | 30.90B |
| April 16, 2024 | 30.93B |
| April 15, 2024 | 31.16B |
| April 12, 2024 | 31.31B |
| April 11, 2024 | 32.22B |
| Date | Value |
|---|---|
| April 10, 2024 | 32.16B |
| April 09, 2024 | 32.59B |
| April 08, 2024 | 32.29B |
| April 05, 2024 | 32.48B |
| April 04, 2024 | 32.48B |
| April 03, 2024 | 32.82B |
| April 02, 2024 | 32.63B |
| April 01, 2024 | 32.95B |
| March 31, 2024 | 32.54B |
| March 28, 2024 | 32.44B |
| March 27, 2024 | 32.41B |
| March 26, 2024 | 31.83B |
| March 25, 2024 | 31.96B |
| March 22, 2024 | 32.03B |
| March 21, 2024 | 32.07B |
| March 20, 2024 | 31.98B |
| March 19, 2024 | 32.04B |
| March 18, 2024 | 31.83B |
| March 15, 2024 | 31.86B |
| March 14, 2024 | 32.07B |
| March 13, 2024 | 32.34B |
| March 12, 2024 | 32.45B |
| March 11, 2024 | 32.75B |
| March 08, 2024 | 32.90B |
| March 07, 2024 | 32.76B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
26.86B
Minimum
Oct 12 2023
59.68B
Maximum
Feb 09 2022
42.23B
Average
43.21B
Median
Enterprise Value Benchmarks
| LeMaitre Vascular Inc | 1.644B |
| Becton Dickinson & Co | 83.41B |
| Boston Scientific Corp | 117.98B |
| ResMed Inc | 33.18B |
| Outset Medical Inc | 154.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 37.00M |
| Revenue (Quarterly) | 3.592B |
| Total Expenses (Quarterly) | 3.373B |
| EPS Diluted (Quarterly) | 0.07 |
| Gross Profit Margin (Quarterly) | 38.61% |
| Profit Margin (Quarterly) | 1.03% |
| Earnings Yield | 14.75% |
| Operating Earnings Yield | 2.88% |
| Normalized Earnings Yield | 0.2567 |